A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine

R.C. Peveler(Royal South Hants Hospital), C. Thompson, Michael J. Campbell(University of Sheffield), Helen Smith(University of York), Louise Longworth(Bielefeld University), Michael Moore(Indiana University School of Medicine), Andrew Thornett, Tony Kendrick(University of Southampton), Iain L. O. Buxton(University of Nevada, Reno), Judy Chatwin, David S. Baldwin(University of Southampton), Jonathan Goddard(Southampton General Hospital)
Health Technology Assessment
May 1, 2005
Cited by 85


Related Papers